Clinical validation of the tempus xT next-generation targeted oncology sequencing assay

We developed and clinically validated a hybrid capture next generation sequencing assay to detect somatic alterations and microsatellite instability in solid tumors and hematologic malignancies. This targeted oncology assay utilizes tumor-normal matched samples for highly accurate somatic alteration...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Beaubier, Nike, Tell, Robert, Lau, Denise, Parsons, Jerod R., Bush, Stephen, Perera, Jason, Sorrells, Shelly, Baker, Timothy, Chang, Alan, Michuda, Jackson, Iguartua, Catherine, MacNeil, Shelley, Shah, Kaanan, Ellis, Philip, Yeatts, Kimberly, Mahon, Brett, Taxter, Timothy, Bontrager, Martin, Khan, Aly, Huether, Robert, Lefkofsky, Eric, White, Kevin P.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481324/
https://ncbi.nlm.nih.gov/pubmed/31040929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26797
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados